Correlation Between MIRA Pharmaceuticals, and Pharvaris

Can any of the company-specific risk be diversified away by investing in both MIRA Pharmaceuticals, and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MIRA Pharmaceuticals, and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MIRA Pharmaceuticals, Common and Pharvaris BV, you can compare the effects of market volatilities on MIRA Pharmaceuticals, and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MIRA Pharmaceuticals, with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of MIRA Pharmaceuticals, and Pharvaris.

Diversification Opportunities for MIRA Pharmaceuticals, and Pharvaris

0.41

Correlation Coefficient

MIRA Pharmaceuticals,  Pharvaris

Very weak diversification

The 3 months correlation between MIRA and Pharvaris is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding MIRA Pharmaceuticals, Common and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and MIRA Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MIRA Pharmaceuticals, Common are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of MIRA Pharmaceuticals, i.e., MIRA Pharmaceuticals, and Pharvaris go up and down completely randomly.

Pair Corralation between MIRA Pharmaceuticals, and Pharvaris

Given the investment horizon of 90 days MIRA Pharmaceuticals, Common is expected to generate 2.03 times more return on investment than Pharvaris. However, MIRA Pharmaceuticals, is 2.03 times more volatile than Pharvaris BV. It trades about 0.01 of its potential returns per unit of risk. Pharvaris BV is currently generating about -0.1 per unit of risk. If you would invest  114.00  in MIRA Pharmaceuticals, Common on December 29, 2024 and sell it today you would lose (8.00) from holding MIRA Pharmaceuticals, Common or give up 7.02% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

MIRA Pharmaceuticals, Common  vs.  Pharvaris BV

MIRA Pharmaceuticals,

Risk-Adjusted Performance

Very Weak

Over the last 90 days MIRA Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, MIRA Pharmaceuticals, is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pharvaris BV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with MIRA Pharmaceuticals, and Pharvaris

The main advantage of trading using opposite MIRA Pharmaceuticals, and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MIRA Pharmaceuticals, position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.

The idea behind MIRA Pharmaceuticals, Common and Pharvaris BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.